Tranexamic acid in dermatology

Abstract

Facial melanoses are Group of pigmentary disorders that share a common clinical feature of alteration of pigmentation over the face. These are difficult to treat and affect the DLQI of the patients. Tranexamic acid is an antifibrinolytic agent which has found to efficacious in a difficult to treat facial melanosis like melasma. It targets the vascular and pigment component of melasma providing a rapid and a sustained improvement. Various studies in different doses and routes in different dermatoses are required to elucidate the exact efficacy of the drug. This article highlights the important dermatological aspects of tranexamic acid in detail.